Loading clinical trials...
Loading clinical trials...
The Effect of Different Treatment Options on Markers of Vascular, Myocardial and Endothelial Function in Women With Polycystic Ovary Syndrome and the Association With Metabolic and Hormonal Abnormalities of the Syndrome
Conditions
Interventions
GLP-1 receptor agonist
Oral contraceptive
+2 more
Locations
1
Greece
Attikon University General Hospital
Chaïdári, Greece
Start Date
February 1, 2024
Primary Completion Date
February 1, 2025
Completion Date
February 1, 2026
Last Updated
November 19, 2025
NCT06793098
NCT06793085
NCT07394530
NCT07399535
NCT07307677
NCT06800170
Lead Sponsor
Attikon Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions